Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-02-25 @ 8:59 PM
Study NCT ID:
NCT00645333
Status:
COMPLETED
Last Update Posted:
2014-04-04
First Post:
2008-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-24
First Submit QC Date:
None
Study First Post Date:
2008-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-09
Results First Submit QC Date:
None
Results First Post Date:
2014-04-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-24
Last Update Post Date:
2014-04-04
Last Update Post Date Type:
ESTIMATED